Oxycodone for Labor Pain - Pharmacokinetics (PK), Safety and Efficacy
Oksiobs
The Efficacy and Safety of Intravenous Oxycodone and Plasma Oxycodone Concentrations in Labour Pain
2 other identifiers
interventional
15
1 country
1
Brief Summary
Childbirth is one of the most painful events that a woman is likely to experience, and thus is a major concern for most parturient. Severe pain releases stress mediators and may thus compromise fetus well-being if placental perfusion is decreased. Epidural analgesia is the golden standard for the management of severe labor pain. However, it could not always be used both due the parturient related factors and the organizational reasons.However, the knowledge on safety and efficacy of oxycodone involving mother, fetus and newborn is limited. Aim of the study is firstly, to evaluate the efficacy and safety of oxycodone in labor pain healthy parturients. Secondly, to measure parturient's blood oxycodone concentration during labour and fetal concentration from placental umbilical vein and artery right after birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 19, 2009
CompletedFirst Posted
Study publicly available on registry
November 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedJanuary 11, 2011
January 1, 2011
1.1 years
November 19, 2009
January 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The efficacy and safety of oxycodone in labor pain
24 hours
Secondary Outcomes (1)
The parturient's blood oxycodone concentration during labour and fetal concentration from placental umbilical vein and artery right after birth
24 hours
Study Arms (1)
Oxycodone, labour pain
OTHERInterventions
Intravenous, 1 mg, 5 times, in every 5 minutes, duration of drug administration 25 minutes
Eligibility Criteria
You may qualify if:
- Labouring healthy women
- Early labour
- Age 18-45 years
You may not qualify if:
- Sleep apnea or other central deficit affecting breathing
- Pulmonary insufficiency
- Liver of kidney insufficiency
- Use of mono amine oxidase medication
- Thyroid, pituitary insufficiency
- Paralytic ileus
- Other contraindication specified by the investigator
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kuopio University Hospital
Kuopio, 70800, Finland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Merja Kokki, PhD
Kuopio University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 19, 2009
First Posted
November 20, 2009
Study Start
November 1, 2009
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
January 11, 2011
Record last verified: 2011-01